Cannabis Innovation Summit

presented by the University of Toronto together with its affiliated hospital partners and the Toronto Cannabis & Cannabinoid Research Consortium (TC3)

Date : Thursday April 4th, 2019

Time : 8:00am – 2:30pm

Location : MaRS Auditorium
Lower Concourse
101 College Street, Toronto

Please register for the Cannabis Innovation Summit: https://www.eventbrite.ca/e/cannabis-innovation-summit-tickets-56215853130

RBC Series with Daniele Piomelli: https://www.eventbrite.ca/e/rbc-innovation-entrepreneurship-speaker-series-with-daniele-piomelli-tickets-56071240590

Description

The use of cannabis for medicinal purposes has opened up a number of questions pertaining to the safety and efficacy for particular disease indications and long term use. This timely summit will discuss the questions that need to be addressed for the health and safety of patients using cannabis to treat disorders, ailments and disease as well as promote the essential evidence-based research that needs to take place in order to address some of these questions.

The Cannabis Innovation Summit will also launch the Toronto Cannabis & Cannabinoid Research Consortium (TC3) which brings together cannabis and cannabinoid researchers, scientists and clinicians from the University of Toronto and its affiliated hospital partners.

The Summit will focus on the drug development of cannabis and cannabinoid related therapies and drug delivery mechanisms from discovery to innovation. It will explore various clinical applications and trials around the assessment of the safety and efficacy of cannabis as a medicine and discuss important societal issues as it relates to mental and body health.

This event will also bring together scientists, government officials, policy-makers, research funding organizations and industry partners who are interested in research and innovation in this field.  The goal of the summit is to offer the opportunity to network, seek new collaborations and share health research findings related to cannabis and cannabinoids.  The symposium will feature talks and panel sessions, and will serve as an interactive platform to highlight preclinical, clinical and public health & policy research in Toronto.

For the full agenda click here (pdf)

Schedule

  • 8:00 – 8:30 am : Registration & Light Breakfast

  • 8:30 – 8:45 am : Opening Remarks

    Dr. Trevor Young
    Dean, Faculty of Medicine, University of Toronto

  • 8:45 – 9:00 am :
    Launch of the Toronto Cannabis & Cannabinoid Research Consortium TC3

    Steering Committee – Dr. Ruth Ross, Dr. Tony George, Dr. Lakshmi P. Kotra,
    Dr. Romina Mizrahi, Dr. Bernard Le Foll

  • 9:00 – 9:50 am : Panel Session – Discovery & Innovation

    This panel discussion will focus on developing safe and effective cannabis and cannabinoid-related therapies and delivery mechanisms, from discovery to innovation.  This panel will also discuss the urgent need to build research capacity in this field to study the harms and side effects of cannabis related therapies.

    Moderator: Dr. Ruth Ross

    Professor and Chair, Department of Pharmacology and Toxicology and Director, Centre for Collaborative Drug Research, University of Toronto
    Senior Scientist, Senior Scientist, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH)

    Dr. Lakshmi Kotra
    Professor of Medicinal Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto
    Senior Scientist, TGHRI University Health Network

    Dr. Christine Allen
    Professor, Interim Dean
    Faculty of Pharmacy University of Toronto

    Dr. Mike Salter
    Chief of Research
    Institute and Senior Scientist, Neurosciences & Mental Health, Hospital for Sick Children

    Eric Marcotte
    Associate Director, Institute of Neurosciences, Mental Health and Addiction, CIHR (CIHR-INMHA)

  • 9:50 – 10:45 am :
    Panel Session – Translation

    The panel will focus on the evidence-based research on the use and safety of cannabis and cannabinoid-related therapies in various therapeutic areas including pain, epilepsy, psychiatry, movement disorders and neurodegenerative disease. This panel will also delve into issues around the concurrent use of cannabis and other medications by patients.

    Moderator: Dr. Tony George

    Professor of Psychiatry, University of Toronto
    Clinician-Researcher and Head, Biobehavioural Addictions and Concurrent Disorders Research Laboratory, CAMH

    Dr. Krista Lanctôt
    Senior scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program,
    Executive director, MORE research group, Sunnybrook Research Institute

    Dr. Hance Clarke
    Director, Pain Services,
    Medical Director, Pain Research Unit
    Medical Director, Ehlers-Danlos Syndrome program, Toronto General Hospital

    Dr. Romina Mizrahi
    Head, Focus on Youth Psychosis Prevention Clinic and Scientist, Research Imaging Centre, Campbell Family Mental Health Research Institute, CAMH

    Dr. W. McIntyre Burnham
    Director, University of Toronto Epilepsy Research Program

    Dr. Susan Fox
    Associate Director, Movement Disorders Clinic and
    Clinical Researcher, Krembil Research Institute, University Health Network

    Dr. Bernard Le Foll
    Head, Alcohol Research and Treatment Clinic,
    Head, Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, CAMH

  • 10:45 – 11:00 am : Short Break

  • 11:00 – 11:50 am :
    Panel Session : Society

    This panel will focus on societal issues pertaining to mental and body health with discussions around youth psychiatry, maternal use and second hand smoke.

    Moderator: Dr. Bruna Brands

    Senior Science Advisor, Office of Drug Science and Surveillance, Controlled Substances Directorate, Health Canada
    Member, Expert Committee on Drug Dependence, World Health Organization

    Dr. Abby Goldstein
    Canada Research Chair in the Psychology of Emerging Adulthood
    Associate Professor, Department of Applied Psychology and Human Development University of Toronto

    Dr. Julia Knight
    Senior Investigator Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
    Professor, Dalla Lana School of Public Health, University of Toronto

    Dr. Pamela Kaufman
    Assistant Professor, Dalla Lana School of Public Health, University of Toronto
    Scientist and Project Lead, Ontario Tobacco Research Unit, Centre for Addiction and Mental Health

    Helen Stevenson
    Founder and CEO, Reformulary Group Inc.

  • 11:50 – 12:30 pm : Keynote Speaker – RBC Entrepreneurship & Innovation Speaker Series

    Daniele Piomelli, PhD

    Professor and Chair, Department of Professor, Anatomy and Neurobiology, University of California Irvine.
    Director, UCI Centre for the Study of Cannabis

    RBC Series with Daniele Piomelli: https://www.eventbrite.ca/e/rbc-innovation-entrepreneurship-speaker-series-with-daniele-piomelli-tickets-56071240590

  • 12:30 – 1:30 pm : Lunch – Concluding Integrative Discussion – How do we make this work in Toronto?

    Dr. Ruth Ross

    Dr. Tony George

    Dr. Daniele Piomelli

    Dr. Bruna Brands

  • 1:30 – 2:30 pm : Closing Remarks – TC3 Launch Networking Event

    A session to network with speakers and delegates from academia, industry, government and other sectors.

Presented By:

In Partnership with:

About Health Innovation Week
From April 1–5, you’re invited to Health Innovation Week, Canada’s largest gathering of health startups, investors and the health ecosystem. Founded by MaRS and TOHealth and held across the Toronto region, Health Innovation Week allows participants to network, secure funding and learn from industry experts. This year we expect to see over 4,000 attendees, 300+ investors and 250+ speakers over 30 events. Learn more.

Back to Top ↑

© 2019 Office of the Vice-President, Research and Innovation. All rights reserved. | Site map | Accessibility | Log in